A multivalent porin mRNA vaccine against diseases caused by Salmonella

Summary 

Infections caused by Salmonella represent a major public health problem globally, even more so with the raise in antimicrobial resistance. In this project we take advantage of mRNA vaccine technology to test several vaccine candidates based on Salmonella porins. The vaccine protection will be evaluated in mice challenged with different Salmonella serovars.

We aim to obtain proof-of-concept evidence that a multivalent Salmonella mRNA vaccine could provide cross protection against endemic, typhoid and non typhoid strains that cause systemic and gastrointestinal manifestations.

 

 

Constantino III Roberto Lopez-MaciasProfessor Constantino III Roberto López-Macías
Head of Unit
Medical Research Unit of Immunochemistry IMSS
Mexico

Collaborators:

Dr Natalia Martin Orozco, Chief Science Officer, R&D Providence Therapeutics Holdings, Inc, Canada

Dr Tania Rivera Hernández, CONAHCYT Fellow-IMSS, Medical Research Unit on Immunochemistry IMSS, Mexico

Professor Adam Cunningham, Professor of Functional Immunity, University of Birmingham, UK